naftopidil has been researched along with propiverine in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hanazawa, K; Honda, S; Kawachi, Y; Koizumi, K; Maruyama, O; Noto, K; Saitoh, T; Sugimura, S; Sugiyama, Y; Yamashita, R | 1 |
Kadekawa, K; Miyazato, M; Nishijima, S; Ogawa, Y; Sugaya, K; Tasaki, S | 1 |
Kumon, H; Nagai, A; Sasaki, K; Uematsu, K; Watanabe, T; Yokoyama, T | 1 |
Hashimoto, Y; Hatakeyama, S; Kamimura, N; Kawaguchi, T; Koie, T; Kudo, S; Ohyama, C; Takahashi, S; Yoneyama, T; Yoshikawa, K | 1 |
Ashitomi, K; Kadekawa, K; Nishijima, S; Sugaya, K; Yamamoto, H | 1 |
Ashitomi, K; Kadekawa, K; Nishijima, S; Sugaya, K; Ueda, T; Yamamoto, H | 1 |
Dahm, P; Gandhi, S; Hwang, EC; Imamura, M; Jung, JH; Kim, MH; Pang, R | 1 |
1 review(s) available for naftopidil and propiverine
Article | Year |
---|---|
Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Benzilates; Drug Combinations; Ethamsylate; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Naphthalenes; Piperazines; Plant Extracts; Prostatic Hyperplasia; Prostatism; Quality of Life; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin; Urological Agents | 2018 |
2 trial(s) available for naftopidil and propiverine
Article | Year |
---|---|
Naftopidil monotherapy vs naftopidil and an anticholinergic agent combined therapy for storage symptoms associated with benign prostatic hyperplasia: A prospective randomized controlled study.
Topics: Adrenergic alpha-Antagonists; Aged; Benzilates; Cholinergic Antagonists; Drug Therapy, Combination; Follow-Up Studies; Humans; Male; Mandelic Acids; Naphthalenes; Piperazines; Prospective Studies; Prostatic Hyperplasia; Treatment Outcome; Urinary Retention; Urodynamics | 2006 |
Naftopidil and propiverine hydrochloride for treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia and concomitant overactive bladder: a prospective randomized controlled study.
Topics: Adrenergic alpha-Antagonists; Aged; Benzilates; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Naphthalenes; Piperazines; Prospective Studies; Prostatic Hyperplasia; Treatment Outcome; Urinary Bladder, Overactive; Urination; Urologic Diseases | 2009 |
4 other study(ies) available for naftopidil and propiverine
Article | Year |
---|---|
Effects of propiverine and naftopidil on the urinary ATP level and bladder activity after bladder stimulation in rats.
Topics: Acetic Acid; Adenosine Triphosphate; Adrenergic alpha-Antagonists; Animals; Benzilates; Cholinergic Antagonists; Drug Interactions; Energy Metabolism; Female; Muscle Contraction; Muscle, Smooth; Naphthalenes; Piperazines; Pressure; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Receptors, Muscarinic; Urinary Bladder; Urinary Bladder, Overactive; Urothelium | 2007 |
[Additional effect of propiverine for naftopidil-resistant nocturia in the patient with benign prostate hypertrophy].
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Benzilates; Cholinergic Antagonists; Drug Resistance; Drug Therapy, Combination; Humans; Male; Middle Aged; Naphthalenes; Nocturia; Piperazines; Prospective Studies; Prostatic Hyperplasia | 2011 |
Excitatory effect of propiverine hydrochloride on urethral activity in rats.
Topics: Adrenergic alpha-Antagonists; Animals; Benzilates; Female; Imidazoles; Indoles; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; Naphthalenes; Piperazines; Prazosin; Pressure; Rats; Rats, Sprague-Dawley; Urethra; Urinary Bladder | 2012 |
Propiverine increases urethral wall catecholamine levels and bladder leak point pressure in rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Animals; Benzilates; Dopamine; Duloxetine Hydrochloride; Imipramine; Injections, Intravenous; Injections, Spinal; Male; Muscarinic Antagonists; Naphthalenes; Norepinephrine; Piperazines; Pressure; Rats; Rats, Sprague-Dawley; Serotonin and Noradrenaline Reuptake Inhibitors; Urethra; Urinary Bladder | 2016 |